November 17, 2019
Loading Events

« All Events

Ophthalmic Drugs

November 19 - November 20

SMi Group are pleased to present the 3rd Annual Ophthalmic Drugs Conference and Focus Day, taking place on the 18th-20th November 2019 in London, UK.

The global ophthalmic drug market size is expected to reach a value of $30 billion USD by 2023 with growing focus on alternative delivery approaches to replace intravitreal drug delivery and novel drug development being the key factors driving the market.

With this in mind, this year’s Ophthalmic Drugsconference willexplore new discoveries in the treatment of ocular rare disease; innovations in gene therapy; the challenges in drug delivery through a complex barrier; patient comfort and regulatory compliance which make up  core components within the Ophthalmic Drug sphere.

NEW FOR 2019:

The brand-new Focus Day on ‘Novel Drug Delivery Through a Complex Barrier’ will bring academic perspectives on the future for ocular drug delivery and notified bodies will provide a regulatory insight into this emerging field of ophthalmic drug development.

How will you benefit?

With over 15 expert presentations, the three-day agenda offers you peer-to-peer networking with Global Product Managers, Heads of Drug Development, Senior Directors of Ophthalmology, Heads of Research and Development and many more!

Network and learn from leading professionals such as:

CHAIRS FOR 2019:

  • Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals
  • Naj Sharif, Vice President, Global Ophthalmology, Santen Inc, USA

FEATURED SPEAKERS INCLUDE:

  • Parisa Zamiri, Global Head of Clinical Development in Ophthalmology, Novartis Pharmaceutical Inc.
  • Gavin Spencer, Executive Vice President and Chief Business Officer, Nicox
  • AnizGirach, Chief Medical Officer, ProQR Therapeutics
  • Daniel Chung, Global Medical Strategy Lead- Ophthalmology, Spark Therapeutics
  • Michael Ehrlich, Senior Clinical Program Lead – Retinopathies, Boehringer Ingelheim
  • Peter Morgan-Warren, Medical Assessor, MHRA
  • William Dallman, Clinical Development Manager, Eyenuk

For more information and to register, visit: www.ophthalmicdrugs.com/pnhq

Early-Bird Rates

  • BOOK BY 28TH JUNE AND SAVE £300
  • BOOK BY 30TH SEPTEMBER AND SAVE £100

Social Media Handles

Follow us on LinkedIn ‘SMi Pharma’, Twitter @SMiPharm and use #OphthalmicDrugs

Additional Contact Info:

T: +44 (0) 20 7827 6164

E: nhoward@smi-online.co.uk

Details

Start:
November 19
End:
November 20
Website:
http://www.ophthalmicdrugs.com/pnhq

Organizer

SMI
Phone:
+44 (0) 20 7827 6164
Email:
nhoward@smi-online.co.uk

Venue

London, UK

To ensure you get the best experience on our website, we use cookies to analyze traffic and for ads measurements purposes including for serving Industry-based ads. By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close